DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Lipocine Inc. (LPCN)
« Back to company indexLPCN Chatter Timeline
Stock Ticker for LPCN
Most Active Tweeters for LPCN
| User | Tweets |
|---|---|
| @dispatchtribune | 2 |
| @TickerReport | 2 |
| @AlertTrade | 1 |
| @richardsgibb1 | 1 |
| @EnterpriseLeade | 1 |
Recent Tweets for LPCN
 |
@StockNewsNow $LPCN Lipocine to Participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma, Rare Disease & Gene… https://t.co/ZBOnYQ1hUt 12:09pm |
 |
@newswithvalue $LPCN: Lipocine to Participate in the Oppenheimer & Co. Fall Summit …: https://t.co/8JABEoDQhs 8:09am |
 |
@WatchlistN Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/83VPligsHK September 15th 2019, 7:09pm |
 |
@richardsgibb1 $lpcn, sold my holding the other day and miraculously hit the very top for $1.50 share gain. Started buying again a… https://t.co/Otz4Enn7R5 September 12th 2019, 10:09am |
 |
@AlertTrade TREND REVERSAL DOWN ALERT: $LPCN Lipocine, Inc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room September 11th 2019, 2:09pm |
 |
@TickerReport Zacks: Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/wwOfVb938r September 10th 2019, 10:09am |
 |
@dispatchtribune Zacks: Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/qu5lLkFA36 September 10th 2019, 10:09am |
 |
@AmericanBanking Zacks: Analysts Expect Lipocine Inc $LPCN Will Announce Earnings of -$0.23 Per Share https://t.co/P5bWPavi8i #stocks September 10th 2019, 10:09am |
 |
@bkfViking123 bullish action ..... waiting for the long green candle. $lpcn September 9th 2019, 7:09pm |
 |
@ahighelevation Counting down to target action date... $LPCN #biotech https://t.co/UwtvrSEb0p https://t.co/80JCH6rINf September 8th 2019, 7:09pm |
 |
@registrarjourn Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/KPAedZUWDr September 8th 2019, 10:09am |
 |
@EnterpriseLeade Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/XVsExMpmxe September 8th 2019, 10:09am |
|
@dispatchtribune Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/5scGyDo3XS September 8th 2019, 10:09am |
|
@TickerReport Lipocine $LPCN Stock Rating Lowered by ValuEngine https://t.co/i7oLHYc4GH September 7th 2019, 5:09pm |
 |
@Gambiste1 RT @ChartMill: $LPCN is one of the better performing stocks in the Drugs industry. https://t.co/83i17ZGIRA https://t.co/xtPGl7oRVa August 8th 2019, 4:08am |
 |
@ChartMill $LPCN is one of the better performing stocks in the Drugs industry. https://t.co/83i17ZGIRA https://t.co/xtPGl7oRVa August 8th 2019, 2:08am |
|
@Gambiste1 RT @MarketCurrents: $LPCN - Lipocine EPS beats by $0.07 https://t.co/dl3RJZ7znt August 7th 2019, 7:08pm |
|
@StockNewsNow $LPCN Lipocine Announces Second Quarter 2019 Financial and Operational Results https://t.co/h3fdvRxWAA August 7th 2019, 1:08pm |
 |
@StockNewsWires $LPCN: Lipocine Announces Second Quarter 2019 Financial and …: https://t.co/EFsQzROqDI August 7th 2019, 8:08am |
 |
@MarketCurrents $LPCN - Lipocine EPS beats by $0.07 https://t.co/dl3RJZ7znt August 7th 2019, 8:08am |
 |
@confcalltran Lipocine Announces Second Quarter 2019 Financial And Operational Results https://t.co/cQZyWRk051 $LPCN August 7th 2019, 8:08am |
|
@confcalltran Lipocine Inc. Just Filed Its Quarterly Report: ... https://t.co/qHvwkgbyGd $LPCN August 7th 2019, 8:08am |
 |
@smallcapwatch RT @ahighelevation: $LPCN Low T Tied to Multiple Ailments #biotech #smallcap #biostock https://t.co/uR1ol0ht6T https://t.co/PglM11NmdO August 6th 2019, 2:08pm |
|
@ahighelevation $LPCN Low T Tied to Multiple Ailments #biotech #smallcap #biostock https://t.co/uR1ol0ht6T https://t.co/PglM11NmdO August 6th 2019, 2:08pm |
|
@Gambiste1 RT @ZacksSmallCap: New TRT Launch Signals Receptive Environment $LPCN #biotech @vanjohn10 #smallcap https://t.co/wJwKyIKtFF https://t.co/A4… August 5th 2019, 4:08pm |
 |
@ZacksSmallCap New TRT Launch Signals Receptive Environment $LPCN #biotech @vanjohn10 #smallcap https://t.co/wJwKyIKtFF https://t.co/A4Dvgr6R1Y August 5th 2019, 1:08pm |
 |
@ZolmaxNews Lipocine $LPCN Stock Passes Below 50 Day Moving Average of $1.84 https://t.co/IasBYLrSHH August 3rd 2019, 9:08pm |
|
@WatchlistN Lipocine $LPCN Stock Passes Below 50 Day Moving Average of $1.84 https://t.co/MLJOEvw0Yi August 3rd 2019, 9:08pm |
 |
@dailypoliticaln Lipocine $LPCN Stock Price Passes Below 50 Day Moving Average of $1.84 https://t.co/QaHK6g9jug August 3rd 2019, 9:08pm |
 |
@1stOncology #Lipocine to Present at the Canaccord Genuity 39th Annual Growth Conference $LPCN https://t.co/Ql9znrCYxV August 2nd 2019, 6:08am |
 |
@macondailynews Lipocine $LPCN Shares Cross Below Fifty Day Moving Average of $1.84 https://t.co/Qmn01eyyum August 1st 2019, 11:08pm |
 |
@TheMarketsDaily Lipocine $LPCN Stock Crosses Below Fifty Day Moving Average of $1.84 https://t.co/01KrVDLwsQ August 1st 2019, 11:08pm |
 |
@stocknewstimes Lipocine $LPCN Shares Cross Below Fifty Day Moving Average of $1.84 https://t.co/rru1XFTmmb August 1st 2019, 11:08pm |
 |
@LifeSciAdvisors Lipocine $LPCN to Present at the Canaccord Genuity 39th Annual Growth Conference https://t.co/wIsIAJECSW July 30th 2019, 2:07pm |
|
@ahighelevation $LPCN New TRT Launch Signals Receptive Environment #biotech https://t.co/7VwFAMsp5i https://t.co/yaWbd5vpQE July 30th 2019, 1:07pm |
|
@StockNewsNow $LPCN Lipocine to Present at the Canaccord Genuity 39th Annual Growth Conference https://t.co/jqgFFfZYK4 July 30th 2019, 12:07pm |
 |
@newswelldone $LPCN: Lipocine to Present at the Canaccord Genuity 39th Annual Growth …: https://t.co/8aiQlDhRwt July 30th 2019, 8:07am |
 |
@vanjohn10 $LPCN to present at Canaccord Genuity Growth Conference 8AUG19 in Boston @ 1:00 pm local. https://t.co/DUUiPt3NaI July 30th 2019, 8:07am |
|
@Gambiste1 RT @ZacksSmallCap: $LPCN: Low T Tied to Multiple Ailments https://t.co/3I9OJ8YQa9 by @vanjohn10 https://t.co/YKXSacV7R2 July 29th 2019, 6:07pm |
|
@ZacksSmallCap $LPCN: Low T Tied to Multiple Ailments https://t.co/3I9OJ8YQa9 by @vanjohn10 https://t.co/YKXSacV7R2 July 29th 2019, 9:07am |
|
@dispatchtribune Lipocine $LPCN Trading Up 1.1% https://t.co/bq9TbIHEO6 July 25th 2019, 2:07pm |
|
@registrarjourn Lipocine $LPCN Shares Up 1.1% https://t.co/wJIjrn9Ze0 July 25th 2019, 2:07pm |
|
@EnterpriseLeade Lipocine $LPCN Shares Up 1.1% https://t.co/z7Z4ts49VM July 25th 2019, 2:07pm |
|
@LifeSciAdvisors Lipocine $LPCN Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Popula… https://t.co/ZRrjcb19o9 July 23rd 2019, 5:07pm |
 |
@MaisaCorp $LPCN Gets FDA OK to Expand Clinical Test Liver Disease Treatment Candidate July 23rd 2019, 3:07pm |
|
@StockNewsNow $LPCN Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Popula… https://t.co/G4agGcwvT1 July 23rd 2019, 11:07am |
 |
@NewsToDesk $LPCN: FDA OKs expanded population for Lipocine’s NASH candidate …: https://t.co/TXtQono5zg July 23rd 2019, 9:07am |
|
@MarketCurrents $LPCN - FDA OKs expanded population for Lipocine's NASH candidate LPCN 1144 https://t.co/OYjGZ6gc0G July 23rd 2019, 8:07am |
|
@bkfViking123 $LPCN next ..... been banging the table on this one https://t.co/8NdUOmn4eu July 23rd 2019, 8:07am |
|
@vanjohn10 $LPCN receives FDA clearance to expand LPCN 1144 studies to include NASH subjects above hypogonadal levels. Could e… https://t.co/PU7e2zWmGg July 23rd 2019, 8:07am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.